Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math

Live updates

1. 23d ago

   Moderna and Merck mRNA Vaccine Reduces Melanoma Recurrence

   Moderna and Merck developed an mRNA vaccine that prevents melanoma from returning, according to trial results. The success of this large-scale trial triggered a surge in Moderna shares and sparked discussions about a potential wave of cancer vaccines. While some observers view the breakthrough as a scientific miracle, others argue that the public hype surrounding the vaccine is currently outstripping the mathematical reality of its impact. The treatment represents a personalized approach to cancer vaccination that could change how physicians treat skin cancer.

   Why it matters

   Melanoma is a highly aggressive form of skin cancer. This partnership utilizes mRNA technology to create personalized vaccines tailored to a patient's specific tumor. The goal is to train the immune system to recognize and destroy remaining cancer cells after primary treatment.

   What is confirmed

   • Moderna and Merck developed an mRNA vaccine that prevents melanoma from returning.
   • Moderna shares increased following the success of the large melanoma vaccine trial.

   Still unconfirmed

   • The hype for the vaccine is running ahead of the math.
   • This breakthrough could lead to a wave of other cancer vaccines.

   What to watch next

   • Expansion of the vaccine trial to other types of cancer.
   Sources used for this update (8)

   1. Reuters — Moderna shares surge as melanoma vaccine with Merck succeeds in large trial
   2. The New York Times — Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
   3. CNN — Moderna, Merck breakthrough could usher in wave of cancer vaccines
   4. The Washington Post — Opinion | A cancer vaccine would be a miracle of science — and the free market
   5. The Economist — It now seems possible to vaccinate against cancer
   6. WSJ — Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math
   7. The Washington Post — What it was like to go through a trial that could revolutionize cancer treatment
   8. National Geographic — Why Scientists Say This Personalized Cancer Vaccine Could Be a Game-Changer
   confidence 90%